Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Nov 13, 2017

30071_dirs_2017-11-13_846b77c4-f246-4fb9-be32-e8f849de8d0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-09

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-09 ResMed Common Stock M 11815 $52.02 Acquired 306615 Direct
2017-11-09 ResMed Common Stock M 20492 $58.24 Acquired 327107 Direct
2017-11-09 ResMed Common Stock M 3625 $27.58 Acquired 330732 Direct
2017-11-09 ResMed Common Stock M 82460 $27.58 Acquired 413192 Direct
2017-11-09 ResMed Common Stock S 11815 $82.71 Disposed 401377 Direct
2017-11-09 ResMed Common Stock S 20492 $82.70 Disposed 380885 Direct
2017-11-09 ResMed Common Stock S 3625 $82.69 Disposed 377260 Direct
2017-11-09 ResMed Common Stock S 82460 $82.70 Disposed 294800 Direct
2017-11-10 ResMed Common Stock F 1858 $83.06 Disposed 292942 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-09 Resmed Stock Option Plan $52.02 M 11815 Disposed 2021-11-19 ResMed Common Stock (11815) Direct
2017-11-09 Resmed Stock Option Plan $58.24 M 20492 Disposed 2022-11-19 ResMed Common Stock (20492) Direct
2017-11-09 Resmed Stock Option Plan $27.58 M 3625 Disposed 2018-11-16 ResMed Common Stock (3625) Direct
2017-11-09 Resmed Stock Option Plan $27.58 M 82460 Disposed 2018-11-16 ResMed Common Stock (82460) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from 82.51 to 82.88. The price reported above represents the weighted average sales price.

F2: This transaction was executed in multiple trades at prices ranging from 82.53 to 82.87. The price reported above represents the weighted average sales price.

F3: This transaction was executed in multiple trades at prices ranging from $82.51 to $82.82. The price reported above reflects the weighted average sale price.

F4: This transaction was executed in multiple trades at prices ranging from 82.49 to 82.89. The price reported above represents the weighted average sales price.

F5: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.

F6: Represents date options first became exercisable. Options vested 1/4 per year.